ArticleNeuro-oncology2025

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Thomas Zeyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.